| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 05/20/1999 | WO1999024043A1 Viscous compositions containing carbon dioxide |
| 05/20/1999 | WO1999024037A1 Use of quinazoline derivatives as tyrosine kinase inhibitors for treating colonic polyps |
| 05/20/1999 | WO1999024035A1 Benzothiazole protein tyrosine kinase inhibitors |
| 05/20/1999 | WO1999023996A2 Compositions containing red rice fermentation products, frementation processes and monascus strains therefor |
| 05/20/1999 | WO1999015160A3 Use of 6,7-substituted 2-aminotetralines suitable for preparing pharmaceutical composition for the therapeutic treatment of inflammatory and/or autoimmune pathologies |
| 05/20/1999 | WO1999007736A3 Lipoprotein-regulating medicaments |
| 05/20/1999 | WO1999007733A3 Hepatitis c inhibitor peptides |
| 05/20/1999 | CA2309609A1 Imidazoylalkyl substituted with a five, six or seven membered heterocyclic ring containing one nitrogen atom |
| 05/20/1999 | CA2309559A1 Hp90: host membrane receptor for pathogenic bacteria, encoded by the bacterial tir gene |
| 05/20/1999 | CA2309319A1 Benzothiazole protein tyrosine kinase inhibitors |
| 05/20/1999 | CA2309317A1 Bovine milk growth factor |
| 05/20/1999 | CA2309162A1 Piperidine derivatives and their use as tachykinin antagonists |
| 05/20/1999 | CA2309121A1 Phenyl-alkyl-imidazoles as h3 receptor antagonists |
| 05/20/1999 | CA2308586A1 H3 receptor ligands of the phenyl-alkyl-imidazoles type |
| 05/20/1999 | CA2308361A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity |
| 05/20/1999 | CA2308359A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity |
| 05/20/1999 | CA2308358A1 Heterocyclic compounds having mmp and tnf inhibitory activity |
| 05/20/1999 | CA2306155A1 Use of quinazoline derivatives as tyrosine kinase inhibitors for treating colonic polyps |
| 05/19/1999 | EP0916729A2 Novel reductase |
| 05/19/1999 | EP0916727A2 Novel LysS |
| 05/19/1999 | EP0916670A2 Pyrrolo-(3,2-b) pyridines and their use as 5-HT1F agonists |
| 05/19/1999 | EP0916346A2 NK-1 receptor antagonists and 5HT3 receptor antagonists for the treatment of emesis |
| 05/19/1999 | EP0916340A1 Suppositories |
| 05/19/1999 | EP0915908A1 Dolastatin pentapeptide derivatives and their use as antitumor agents |
| 05/19/1999 | EP0915876A1 Tricyclic benzazepine vasopressin antagonists |
| 05/19/1999 | EP0915864A1 Gastroprotective flavone/flavanone compounds with therapeutic effect on inflammatory bowel disease |
| 05/19/1999 | EP0915847A1 Substituted sulfonamides as selective beta3 agonists for the treatment of diabetes and obesity |
| 05/19/1999 | EP0915826A1 Smooth muscle spasmolytic agents, compositions and methods of use thereof |
| 05/19/1999 | EP0915704A1 Use of phosphinyloxyalkyl and phosphonamidoalkyl derivatives of cyclopentane(ene) as therapeutic agents |
| 05/19/1999 | EP0915651A1 Il-8 receptor antagonists |
| 05/19/1999 | EP0752986B1 N-heterocyclyl sulphonamide derivatives and their use as endothelin antagonists |
| 05/19/1999 | CN1217022A Therapeutic uses of keratinocyte growth factor |
| 05/19/1999 | CN1216989A Process for preparing magnesium salt of substituted sulphinyl heterocycle |
| 05/19/1999 | CN1216915A Storage stable dentifrice composition contg. casein |
| 05/19/1999 | CN1216767A Novel 5-membered ring heterocycles, their prepn. their use and pharmaceutical preparations comprising them |
| 05/18/1999 | US5905084 5-HTIF -agonists effective in treating migraine |
| 05/18/1999 | US5905081 Topical formulations of azathioprine to treat inflammatory bowel disorders |
| 05/18/1999 | US5905080 Central nervous system, psychological, eating disorders; cognition activators, parkinson*s disease |
| 05/18/1999 | CA2179264C 6-(2-imidazolinylamino)quinoline compounds useful as alpha-2 adrenoceptor agonists |
| 05/14/1999 | WO1999023217A1 A novel gene and uses therefor |
| 05/14/1999 | WO1999023076A1 Therapeutically active compounds based on indazole bioisostere replacement of catechol in pde4 inhibitors |
| 05/14/1999 | WO1999022749A1 Galenic preparation for prevention and treatment of hepatocarcinoma |
| 05/14/1999 | WO1999022748A1 Remedies for ulcerative colitis |
| 05/14/1999 | WO1999022741A1 Antimutagenic compositions for treatment and prevention of photodamage to skin |
| 05/14/1999 | WO1999022733A1 Novel metal complexes |
| 05/14/1999 | WO1999007351A3 Indole derivatives and their use as mcp-1 antagonists |
| 05/14/1999 | WO1999001467A3 Therapeutically active compounds with low systemic activity due to reduce half life |
| 05/14/1999 | WO1998047480A3 Membrane system for controlled tissue regeneration in cases of diseases of the peridontium |
| 05/14/1999 | WO1997035539A3 Arylamino fused pyridines and pyrimidines |
| 05/14/1999 | CA2309175A1 Therapeutically active compounds based on indazole bioisostere replacement of catechol in pde4 inhibitors |
| 05/14/1999 | CA2308385A1 Antimutagenic compositions for treatment and prevention of photodamage to skin |
| 05/14/1999 | CA2308317A1 Novel metal complexes |
| 05/14/1999 | CA2307839A1 Gene involved in metabolic energy and obesity |
| 05/12/1999 | EP0915087A2 Sulfonamide substituted fused five-membered ring compounds, their use as medicaments as well as pharmaceutical compositions containing them |
| 05/12/1999 | EP0915086A1 Phenylsulfonamide derivatives |
| 05/12/1999 | EP0914432A2 Secreted proteins and polynucleotides encoding them |
| 05/12/1999 | EP0914414A1 Laminin 5 for growth of pancreatic islet cells |
| 05/12/1999 | EP0914341A1 Antagonists of intestinotrophic glp-2 peptides |
| 05/12/1999 | EP0914322A1 New indolyl and benzofuranyl carboxamides as inhibitors of nitric oxide production |
| 05/12/1999 | EP0914319A1 Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists |
| 05/12/1999 | EP0914160A2 Hydrophobic carbomer complex compositions |
| 05/12/1999 | EP0914102A1 Compositions and methods for treating or preventing diseases of body passageways |
| 05/12/1999 | EP0914081A1 Storage stable dentifrice composition containing casein glycomacropeptide |
| 05/12/1999 | EP0914040A1 Antimicrobial composition and methods of use therefor |
| 05/12/1999 | EP0733067B1 N-terminally chemically modified protein compositions and methods |
| 05/12/1999 | EP0696281B1 Novel 5-pyrrolyl-2-pyridylmethylsulfinyl benzimidazole derivatives |
| 05/12/1999 | EP0627900B1 Use of injectable collagen biomaterials for the repair and augmentation of the anal sphincters |
| 05/12/1999 | CN1216547A Proton pump inhibitor |
| 05/12/1999 | CN1216527A Process for scavenging thiols |
| 05/12/1999 | CN1216472A A pharmaceutical formulation containing growth hormone, an amino acid and a non-ionic detergent |
| 05/12/1999 | CN1216256A Galenic preparation for prevention and treatment of hepatocarcinoma |
| 05/11/1999 | US5902810 Pteridine derivatives as no synthase inhibitors |
| 05/11/1999 | US5902803 5H,10H-imidazo 1,2-a!indeno 1,2-e!pyrazin-4-one derivatives, preparation thereof, and drugs containing said derivatives |
| 05/11/1999 | US5902791 Metalloproteinase inhibitors |
| 05/06/1999 | WO1999022243A1 148 human secreted proteins |
| 05/06/1999 | WO1999021860A1 Phenanthroline derivatives |
| 05/06/1999 | WO1999021857A1 3-substituted tetrahydropyridopyrimidinone derivatives, method for producing the same, and their use |
| 05/06/1999 | WO1999021846A1 Cyclopentene derivatives useful as antagonists of the motilin receptor |
| 05/06/1999 | WO1999021834A1 Heteroaryl diazacycloalkanes as cholinergic ligands at nicotinic acetylcholine receptors |
| 05/06/1999 | WO1999021831A1 Tricyclic compounds as cgmp-pde inhibitors |
| 05/06/1999 | WO1999021830A1 Process for stereoselective synthesis of prostacyclin derivatives |
| 05/06/1999 | WO1999021824A1 Cyclic amino acids and derivatives thereof useful as pharmaceutical agents |
| 05/06/1999 | WO1999021617A2 Allosteric adenosine receptor modulators |
| 05/06/1999 | WO1999021570A1 Citrus peel extract as inhibitor of acyl coa-cholesterol-o-acyltransferase, inhibitor of macrophage-lipid complex accumulation on the arterial wall and preventive or treating agent for hepatic diseases |
| 05/06/1999 | WO1999021567A1 Pharmaceutical compositions for oral administration of molecular iodine |
| 05/06/1999 | WO1999021559A1 MORPHOLINO-N-ETHYL ESTER PRODRUGS OF INDOLE sPLA2 INHIBITORS |
| 05/06/1999 | WO1999021557A1 Antagonists of gonadotropin releasing hormone |
| 05/06/1999 | WO1999021553A1 Antagonists of gonadotropin releasing hormone |
| 05/06/1999 | WO1999021550A1 Use of coumarin derivatives for the treatment of digestive tract disorders |
| 05/06/1999 | WO1999021549A1 Hesperidin and hesperetin as inhibitor of acyl coa-cholesterol-o-acyltransferase, inhibitor of macrophage-lipid complex accumulation on the arterial wall and preventive or treating agent for hepatic diseases |
| 05/06/1999 | WO1999021548A1 Naringin and naringenin as inhibitor of acyl coa-cholesterol-o-acyltransferase, inhibitor of macrophage-lipid complex accumulation on the arterial wall and preventive or treating agent for hepatic diseases |
| 05/06/1999 | WO1999021546A1 N,N-DIETHYLGLYCOLAMIDO ESTER PRODRUGS OF INDOLE sPLA2 INHIBITORS |
| 05/06/1999 | WO1999015493A8 9,10-dihydro-9,10-ethanoanthracene derivatives as phospholipase inhibitors |
| 05/06/1999 | WO1999008691A3 Use of locally delivered metal ions for treatment of periodontal disease |
| 05/06/1999 | EP0913481A2 Staphylococcus aureus member of the DEAD-type ATP-dependent RNA helicases (dbpB) |
| 05/06/1999 | EP0913396A2 Sulphonamide substituted benzopyran derivatives, process of preparation, their use as medicines and pharmaceutical compositions containing them |
| 05/06/1999 | EP0913157A1 A new composite vaccine which contains antigen, antibody and recombinant dna and its preparing method |
| 05/06/1999 | EP0913155A2 Pharmaceutical formulation for treating liver disorders |
| 05/06/1999 | EP0913151A1 Anti-helicobacter pylori compositions containing 1-methylcarbapenem derivatives as the active ingredient |
| 05/06/1999 | EP0912601A1 Suppression of immune response via inhibition of cathepsin s |